Inclusion Criteria:
  -  Diagnosis of ALS or PLS
  -  Age greater than 18 years
  -  Clinically significant spasticity.
Exclusion Criteria:
  -  Individuals currently taking carbidopa-levodopa or with known hypersensitivity of any component of carbidopa-levodopa
  -  Narrow-angle glaucoma
  -  Current use of a non-selective monoamine oxidase inhibitor (MAOI)
  -  History of malignant melanoma or suspicious skin lesions
  -  History of depression, suicidal ideation, or psychosis
  -  History of myocardial infarction, ventricular arrhythmia, or severe cardiopulmonary disease
  -  Uncontrolled hypertension
  -  Asthma
  -  Renal disease
  -  Hepatic disease
  -  Endocrine disease
  -  History of peptic ulcer
  -  Pregnant and/or breastfeeding
  -  Current participation in another interventional study